Feasibility study of Capecitabine as adjuvant chemotherapy for stage III colon cancer including RS [rectosigmoid] cancer.
Phase of Trial: Phase IV
Latest Information Update: 03 May 2017
At a glance
- Drugs Capecitabine (Primary)
- Indications Colorectal cancer
- Focus Therapeutic Use
- 30 Apr 2017 Status changed from active, no longer recruiting to completed.
- 25 May 2011 Status changed from recruiting to active, no longer recruiting as reported by University Hospital Medical Information Network - Japan.
- 22 Oct 2008 New trial record.